This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Molson Coors (TAP) Rises 15% YTD: Can the Momentum Continue?
by Zacks Equity Research
Molson Coors (TAP) benefits from investments, partnerships and product launches as part of its Revitalization Plan. Innovation and premiumization efforts as well as hard seltzer ambition bode well.
Monster Beverage (MNST) Q2 Earnings & Sales Beat, Costs Hurt
by Zacks Equity Research
Monster Beverage (MNST) reports strong Q2 results despite headwinds from shortages in aluminum can supplies, global port congestion, and higher input and freight costs.
PepsiCo (PEP) Agrees to Offload Its Juice Brands to PAI
by Zacks Equity Research
PepsiCo (PEP) unveils plans to offload juice businesses, including Tropicana, to PAI for $3.3 billion. The deal will help it focus on expanding on-trend brands and expand margins.
Keurig Dr Pepper (KDP) Tops on Q2 Earnings & Sales, Hikes View
by Zacks Equity Research
Keurig Dr Pepper (KDP) sees robust business trends across segments in Q2 due to increased consumer mobility, which translates into improved away-from-home channel sales. It raises 2021 sales view.
FEMSA (FMX) Q2 Earnings Miss, Rise Y/Y on Recovered Trends
by Zacks Equity Research
Recovery across markets and business units, as consumers return to stores, aid FEMSA (FMX) in Q2. The company reports strong y/y comparisons across all units.
Boston Beer (SAM) Falls on Q2 Earnings & Sales Miss, Cuts View
by Zacks Equity Research
Boston Beer's (SAM) Q2 results reflect slowed growth trends in hard seltzer and lower-than-anticipated demand for the Truly brand. Increased costs and lower margins have been other headwinds.
Coca-Cola (KO) Tops Q2 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Coca-Cola (KO) witnesses positive revenue trends in Q2, owing to ongoing recovery across most markets due to the subsiding of the pandemic-led headwinds. It raises the 2021 view.
Bear of the Day: The Boston Beer Company (SAM)
by Jeremy Mullin
The party looks to be over for this beer name.
Monster Beverage (MNST) Rises 25.4% in a Year: More Room to Run?
by Zacks Equity Research
Monster Beverage (MNST) looks poised for growth, backed by strength in its energy drinks business as well as a robust pipeline of innovative product launches.
Here's Why You Should Hold on to AB InBev (BUD) Stock Now
by Zacks Equity Research
AB InBev (BUD) has been an investor favorite on a strong brand portfolio, commercial strategy, and investments in digital and operational excellence. Premiumization efforts have also been aiding.
Constellation Brands (STZ) Misses on Q1 Earnings, Updates View
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results gain from robust growth in the beer business despite soft wine and spirits performance. It provides an upbeat view for fiscal 2022.
3 Reasons Why You Must Hold Diageo (DEO) in Your Portfolio
by Zacks Equity Research
Diageo (DEO) is poised to retain its market position through investments in online and the booming RTD category. Higher costs and disruptions in Travel Retail and on-trade businesses are headwinds.
Here's Why You Should Hold on to FEMSA (FMX) Stock for Now
by Zacks Equity Research
FEMSA (FMX) stock is worth holding on to, driven by its expansion initiatives and growth via acquisition strategy. It is also on track with digital investments to boost customer experiences.
FEMSA (FMX) Fortifies Presence in US Specialized Distribution
by Zacks Equity Research
FEMSA (FMX) is on track to expand presence in the specialized distribution industry in the United States through the acquisition of two independent businesses in the industry.
FEMSA (FMX) Q2 Earnings & Sales Down Y/Y on Coronavirus Woes
by Zacks Equity Research
FEMSA (FMX) second-quarter results reflect significant impacts of the coronavirus outbreak across all segments caused by restrictions on mobility, soft consumer demand and lower supplies.
FEMSA (FMX) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
FEMSA (FMX) delivers strong first-quarter 2020 results on robust top-line growth and higher operating income across most of its business units amid the coronavirus crisis.
Diageo (DEO) Hurt by Coronavirus Impact, Withdraws FY20 View
by Zacks Equity Research
Diageo (DEO) withdraws FY20 view, cuts expenses and suspends share repurchase plan in the wake of the uncertain COVID-19 impacts. Also, its top line remains soft due to lockdown in many countries.
Outlook for Alcohol Industry Dim on Soft Beer Sales & Tariffs
by Zacks Equity Research
Beer brands are struggling due to industry-wide softening of volumes. But, the industry can revive on product innovation, premiumization, use of natural ingredients and cannabis-infused drinks.
FEMSA to Enter U.S. Cash & Carry Segment With JRD Stakes
by Zacks Equity Research
FEMSA (FMX) signs a Memorandum of Understanding to buy a minority stake in Jetro Restaurant Depot. The deal will mark its entry in the U.S. wholesale cash and carry business.
Here's Why FEMSA (FMX) Deserves a Place in Your Portfolio
by Zacks Equity Research
FEMSA (FMX) witnesses positive momentum, owing to earnings beat in second-quarter 2019 and rise in sales. Additionally, the company's growth and expansion efforts place it well for long-term growth.
AB InBev Unit Revisits Hong Kong Listing, Plans $5B IPO
by Zacks Equity Research
AB InBev (BUD) revisits Hong Kong listing, with improved market conditions and an attractive offer for investors.
Know the FEMSA (FMX) Stock In and Out Before You Invest
by Zacks Equity Research
FEMSA (FMX) gains from initiatives like expanding store base, diversifying the business portfolio and focusing on core business. But soft margin trend and increased costs are deterrents.
FEMSA Comercio to Expand in Brazil With 50% Stake in Raizen
by Zacks Equity Research
FEMSA Comercio to buy a 50% stake in the Brazilian Raizen Conveniencias for R$561 million. This move is likely to prove beneficial to FEMSA (FMX).
Here's Why AB InBev (BUD) Withdraws $9.8B IPO in Hong Kong
by Zacks Equity Research
AB InBev (BUD) withdraws the planned $9.8-billion IPO for its Budweiser unit in Asia, which would have been the world's biggest IPO for 2019 after Uber's $8.1-billion offering.
FEMSA Stock in Doldrums: Can Growth Plans Offset Headwinds?
by Zacks Equity Research
FEMSA (FMX) is in doldrums, thanks to the negative operating margins trend stemming from softness at its operating segments. Its portfolio diversification efforts may cushion the stock.